FdaApplication
NDA 202211
Identifiers
- fda_app_no: NDA202211
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE |
| application_type | NDA |
| approval_date | 2013-01-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXYTROL FOR WOMEN | OXYBUTYNIN | 3.9MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL |
1 product